1. Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus.
- Author
-
Peixoto EB, Papadimitriou A, Lopes de Faria JM, and Lopes de Faria JB
- Subjects
- Albuminuria metabolism, Albuminuria prevention & control, Albuminuria urine, Animals, Antioxidants pharmacology, Blotting, Western, Caspase 3 metabolism, Cell Line, Transformed, Diabetes Mellitus, Experimental chemically induced, Diabetes Mellitus, Experimental metabolism, Fluorescent Antibody Technique, Humans, Kidney Glomerulus drug effects, Kidney Glomerulus metabolism, Kidney Glomerulus pathology, Male, Membrane Proteins metabolism, Membrane Proteins urine, Mice, Oxidative Stress drug effects, Phenanthrenes pharmacology, Podocytes metabolism, Podocytes pathology, Poly(ADP-ribose) Polymerase Inhibitors, Rats, Rats, Inbred SHR, Spin Labels, Streptozocin, Apoptosis drug effects, Cyclic N-Oxides pharmacology, Diabetes Mellitus, Experimental prevention & control, Podocytes drug effects, Poly(ADP-ribose) Polymerases metabolism, Signal Transduction drug effects
- Abstract
Background/aims: In diabetic hypertensive rats, tempol reduces albuminuria by restoring the redox imbalance. Increased formation of reactive oxygen species leading to activation of poly(ADP-ribose) polymerase (PARP)-1 and podocyte loss by apoptosis contribute to albuminuria in diabetes mellitus (DM). In the present study, we investigated the hypothesis that in DM tempol reduces albuminuria by inhibition of PARP-induced podocyte apoptosis., Methods: DM was induced in 4-week-old spontaneously hypertensive rats by streptozotocin. Mouse and human podocyte cell lines were cultured in normal or high-glucose conditions, with or without tempol and/or a PARP-1 inhibitor, PJ34., Results: In diabetic rats, tempol treatment did not affect plasma glucose levels or systolic blood pressure. Albuminuria was higher in diabetic rats, and it was reduced by tempol. DM leads to an elevation of glomerular apoptotic cells and to podocyte loss; both were prevented by tempol treatment. DM increases the expression of poly(ADP-ribose)-modified proteins in isolated glomeruli, and it was reduced by tempol. In vitro, high glucose increased caspase-3 activity and led to a higher number of apoptotic cells that were prevented by tempol and the PARP-1 inhibitor., Conclusion: In DM, tempol reduces albuminuria associated with reduction of podocyte apoptosis and decreasing oxidative stress via PARP signaling., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF